ADC company nets $137M Read in browser

Thank you for reading, dupa dupackia! basic Subscription UPGRADE

M T Wed Th F 8 April, 2026

John Carroll’s R&D 15 report is back — and this year, he’s bringing some of the industry’s top research chiefs into the conversation to break down what the data means, what’s shifting, and where biopharma R&D is headed. Join us to find out what comes next.

presented by Pre­sent­ing Your Gene Ther­a­py Man­u­fac­tur­ing Plan to In­vestors: What They Ex­pect in 2026 and How to De­liv­er It

news European VC Jeito gets $1.2B to help private biotechs control their 'destiny' Insmed shelves Brinsupri in skin disease after mid-stage flop ADC biotech Sidewinder collects $137M for bispecific approach

Apr 28 12:30 pm ET Connection ≠ continuity: Rethinking long-term evidence in the age of tokenization sponsored by PicnicHealth Apr 29 12:00 pm ET From genotype to outcomes: Real-world evidence in glomerular diseases sponsored by Natera May 05 11:00 am ET The path to self-driving: Leveraging agentic AI to drive the future of clinical drug development sponsored by Medable May 12 10:30 am ET Rules of engagement: How G3BP2 paves the way to rationalize novel degrons sponsored by Thermo Fisher

AI has gone from buzzword to pipeline strategy — but are the results a mixed bag? We're talking to the researchers in the thick of it about what's moving the needle, what's stalling out and what comes next. Join us for a free virtual program, then continue the conversation at an in-person-only fireside and happy hour in Boston. Choose your pass.

ENDPOINTS PHARMA Eli Lilly's latest acquisition could preview another booming market White House adds AbbVie's Humira to TrumpRx alongside cheaper biosimilars Study suggests $35 monthly insulin cap has increased patient access

in case you missed it 1. Updated: Gilead continues dealmaking streak with $3.15B Tubulis buy for ADCs 2. Merck got a peek at Terns' leukemia data during its deal talks — and decided to lower its bid by $1B 3. Sanofi bispecific sails through asthma, sinusitis trials but disappoints in eczema 4. News Briefing Novo launches high-dose Wegovy in the US; Evotec pressured to list its US unit 5. ARPA-H selects three academic teams in $100M effort to repair and regrow ailing joints 6. BioNTech to shutter Singapore HQ after 'comprehensive review' 7. Is a new weight-loss drug making people fall out of love?